BD (NYSE:BDX) announced today that it launched its Neopak XtraFlow glass prefillable syringe and expanded capacity for the platform. The company said the launch and expansion aim to serve the growing market for biologic therapies. Neopak glass prefillable syringes address key development needs for biologic drugs, BD said in a news release. The syringes have…

Eli Lilly and Co. recently announced that it’s spending $1 billion to expand its Limerick, Ireland, manufacturing site. The goal of the expansion, announced Sept. 12, is to increase the production of biologic active ingredients, including those for the company’s recently approved treatment for early symptomatic Alzheimer’s disease. The company announced in July that the…

Sanofi announced today that it’s shipping Beyfortus injection doses to the U.S. to ensure availability ahead of respiratory syncytial virus (RSV) season. The company shipped 50mg and 100mg injection doses of Beyfortus (nirsevimab-alip) to private healthcare providers and the Centers for Disease Control and Prevention for its Vaccines for Children program. Sanofi expects the U.S.…

The API Innovation Center (APIIC) announced that it received $14 million in U.S. government funding to lead a pharmaceutical production project. The Administration for Strategic Preparedness and Response’s (ASPR) Center for Industrial Base Management and Supply Chain (IBMSC) provided the funding for APIIC to lead the development and domestic production of three critical active pharmaceutical…

Evonik announced today that it opened a new facility for drying aqueous dispersions of EUDRAGIT polymers at its site in Darmstadt, Germany. The new, double-digit million-euro excipient manufacturing facility enables the Essen, Germany-based company to meet increasing demand from pharmaceutical customers for oral drug delivery solutions. EUDRAGIT polymers — polymethacrylates  — are suitable for use…

Emergent BioSolutions says it will donate 50,000 doses of its ACAM2000 smallpox vaccine to help against the mpox outbreak in Africa. According to Emergent, the FDA is presently reviewing a supplemental Biologics License Application (sBLA) to expand ACAM2000’s indication to include mpox immunization. The company expects the FDA to complete its review in the third…

LSPedia and Pharma Logistics announced a strategic partnership to transform the pharmaceutical supply chain. LSPedia, a SaaS solution leader, offers global product traceability. Pharma Logistics provides pharmaceutical reverse distribution. Pharma Logistics’ offerings ensure efficient and safe handling of pharmaceutical products throughout their end-of-life cycle. LSPedia brings to the partnership the OneScan solution for achieving complete…

Pfizer recently opened an extension of its highly automated active pharmaceutical ingredient (API) manufacturing facility in Tuas Biomedical Park in Singapore. The 429,000 ft2 expansion cost SGD $1 billion (U.S. $745 million), according to a July 23 news release from the Singapore Economic Development Board. Pfizer has passed final performance qualification checks at the facility…

Sanofi recently announced that it will spend €1.3 billion ($1.4 billion) over the next five years to build a new insulin production facility at its BioCampus in Frankfurt Höchst, Germany. The 36,000 m2 (equivalent to nearly 388,000 ft2) facility will replace existing insulin production plants. Paris-based Sanofi says several hundred highly qualified specialists will work…

Catalent (NYSE:CTLT) announced today that it completed the expansion of its clinical supply facility in Schorndorf, Germany. The Somerset, New Jersey-based company’s Schorndorf site is its flagship European facility. It provides comprehensive clinical supply services, including packaging, storage and distribution. Catalent originally opened the Schorndorf facility in 1996. It provides comprehensive clinical supply services, including…